In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 0.0 | 0.0 | 0.2 | 0.2 | 1.3 | 0.0 | 1.2 | 0.0 | 0.0 | 0.0 | 0.4 | 0.3 | |
| Other Income | 0.2 | 0.3 | 0.3 | 0.2 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.1 | |
| Total Income | 0.2 | 0.3 | 0.5 | 0.3 | 1.6 | 0.2 | 1.4 | 0.2 | 0.3 | 0.2 | 0.7 | 0.4 | |
| Expenses | |||||||||||||
| + Cost of Materials Consumed | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| + Changes in Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| + Employee Benefit Expense | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.3 | 0.6 | 0.1 | 0.2 | 0.2 | |
| + Finance Costs | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.4 | 0.1 | 0.1 | 0.1 | |
| + Depreciation & Amortisation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Other Expenses | 0.3 | 0.3 | 0.2 | 0.3 | 0.6 | 0.4 | 0.4 | 0.3 | 0.6 | 0.3 | 0.4 | 0.2 | |
| Total Expenses | 0.9 | 0.9 | 1.0 | 0.9 | 1.2 | 1.0 | 1.1 | 0.9 | 1.7 | 0.6 | 0.8 | 0.5 | |
| EBITDA | -0.6 | -0.7 | -0.6 | -0.5 | 0.3 | -0.7 | 0.3 | -0.6 | -1.2 | -0.4 | -0.2 | -0.1 | |
| EBIT | -0.6 | -0.7 | -0.6 | -0.5 | 0.3 | -0.7 | 0.3 | -0.7 | -1.2 | -0.4 | -0.2 | -0.1 | |
| Profit | |||||||||||||
| PBT before Exceptional Items | -0.7 | -0.6 | -0.5 | -0.6 | 0.5 | -0.8 | 0.2 | -0.7 | -1.4 | -0.3 | -0.1 | -0.1 | |
| + Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.3 | -0.0 | 0.0 | |
| Pretax Income | -0.7 | -0.6 | -0.5 | -0.6 | 0.5 | -0.8 | 0.2 | -0.7 | -1.4 | -3.7 | -0.1 | -0.1 | |
| Net Income | -0.7 | -0.6 | -0.5 | -0.6 | 0.5 | -0.8 | 0.2 | -0.7 | -1.4 | -3.7 | -0.1 | -0.1 | |
| + Net Income — Continuing Ops | -0.7 | -0.6 | -0.5 | -0.6 | 0.5 | -0.8 | 0.2 | -0.7 | -1.4 | -3.7 | -0.1 | -0.1 | |
| + Other Comprehensive Income | 0.0 | 0.2 | 0.2 | 0.1 | 0.0 | -0.0 | 0.0 | 0.0 | 0.0 | -0.0 | -0.1 | 0.0 | |
| Total Comprehensive Income | -0.7 | -0.4 | -0.4 | -0.5 | 0.5 | -0.8 | 0.2 | -0.7 | -1.4 | -3.7 | -0.2 | -0.1 | |
| Per Share | |||||||||||||
| Basic EPS | -0.34 | -0.32 | -0.27 | -0.30 | 0.23 | -0.40 | 0.11 | -0.36 | -0.68 | -1.84 | -0.07 | -0.05 | |
| Diluted EPS | -0.34 | -0.32 | -0.27 | -0.30 | 0.23 | -0.40 | 0.11 | -0.36 | -0.68 | -1.84 | -0.07 | -0.05 | |
| Other Comprehensive Income — detail | |||||||||||||
| + Other Comprehensive Income | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | -0.0 | -0.1 | 0.0 | |
| + Items NOT to be Reclassified to P&L | 0.0 | 0.2 | 0.2 | 0.1 | 0.0 | -0.0 | 0.0 | 0.0 | 0.0 | -0.0 | -0.1 | 0.0 | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS — Continuing Operations | -0.34 | -0.32 | -0.27 | -0.30 | 0.23 | -0.40 | 0.11 | -0.36 | -0.68 | -1.84 | -0.07 | -0.05 | |
| Diluted EPS — Continuing Operations | -0.34 | -0.32 | -0.27 | -0.30 | 0.23 | -0.40 | 0.11 | -0.36 | -0.68 | -1.84 | -0.07 | -0.05 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | 0.5 | — | 0.2 | — | 0.3 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||||||||
| Gross Profit | -0.0 | -0.0 | 0.2 | 0.2 | 1.3 | 0.0 | 1.2 | 0.0 | 0.0 | 0.0 | 0.4 | 0.2 | |
| Gross Margin % | — | — | 94.94 | 96.06 | 100.00 | — | 100.00 | — | — | — | 100.00 | 78.60 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||||||||
| Pretax Income (Adjusted, as filed) | -0.7 | -0.6 | -0.5 | -0.6 | 0.5 | -0.8 | 0.2 | -0.7 | -1.4 | -0.3 | -0.1 | -0.1 | |
| − Exceptional Items (reconciliation) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.3 | -0.0 | 0.0 | |
| Net Income Adj (tax-effected) | -0.7 | -0.6 | -0.5 | -0.6 | 0.5 | -0.8 | 0.2 | -0.7 | -1.4 | -0.3 | -0.1 | -0.1 | |
| EPS Adj | -0.34 | -0.32 | -0.27 | -0.30 | 0.23 | -0.40 | 0.11 | -0.36 | -0.68 | -0.17 | -0.05 | -0.05 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | |
| Paid Up Equity Capital | 10.0 | 10.0 | 10.0 | 10.0 | 10.0 | 10.0 | 10.0 | 10.0 | 10.0 | 10.0 | 10.0 | 10.0 | |